These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Counteraction of type 1 diabetic alterations by engineering skeletal muscle to produce insulin: insights from transgenic mice. Riu E; Mas A; Ferre T; Pujol A; Gros L; Otaegui P; Montoliu L; Bosch F Diabetes; 2002 Mar; 51(3):704-11. PubMed ID: 11872670 [TBL] [Abstract][Full Text] [Related]
13. Electrogenetic cellular insulin release for real-time glycemic control in type 1 diabetic mice. Krawczyk K; Xue S; Buchmann P; Charpin-El-Hamri G; Saxena P; Hussherr MD; Shao J; Ye H; Xie M; Fussenegger M Science; 2020 May; 368(6494):993-1001. PubMed ID: 32467389 [TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide-1 plasmid construction and delivery for the treatment of type 2 diabetes. Choi S; Oh S; Lee M; Kim SW Mol Ther; 2005 Nov; 12(5):885-91. PubMed ID: 16039908 [TBL] [Abstract][Full Text] [Related]
16. Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis. Kumar DP; Asgharpour A; Mirshahi F; Park SH; Liu S; Imai Y; Nadler JL; Grider JR; Murthy KS; Sanyal AJ J Biol Chem; 2016 Mar; 291(13):6626-40. PubMed ID: 26757816 [TBL] [Abstract][Full Text] [Related]
17. Multipotent mesenchymal stromal cells enhance insulin secretion from human islets via N-cadherin interaction and prolong function of transplanted encapsulated islets in mice. Montanari E; Meier RPH; Mahou R; Seebach JD; Wandrey C; Gerber-Lemaire S; Buhler LH; Gonelle-Gispert C Stem Cell Res Ther; 2017 Sep; 8(1):199. PubMed ID: 28962589 [TBL] [Abstract][Full Text] [Related]
18. Far-red light-activated human islet-like designer cells enable sustained fine-tuned secretion of insulin for glucose control. Yu G; Zhang M; Gao L; Zhou Y; Qiao L; Yin J; Wang Y; Zhou J; Ye H Mol Ther; 2022 Jan; 30(1):341-354. PubMed ID: 34530162 [TBL] [Abstract][Full Text] [Related]
19. Glucagon receptor antagonism promotes the production of gut proglucagon-derived peptides in diabetic mice. Lang S; Wei R; Wei T; Gu L; Feng J; Yan H; Yang J; Hong T Peptides; 2020 Sep; 131():170349. PubMed ID: 32561493 [TBL] [Abstract][Full Text] [Related]
20. Acute disruption of glucagon secretion or action does not improve glucose tolerance in an insulin-deficient mouse model of diabetes. Steenberg VR; Jensen SM; Pedersen J; Madsen AN; Windeløv JA; Holst B; Quistorff B; Poulsen SS; Holst JJ Diabetologia; 2016 Feb; 59(2):363-70. PubMed ID: 26537124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]